17th Annual Mifepristone Medical Abortion Meeting

Gynuity welcomed over 100 clinicians, researchers, donors, women’s health advocates and pharmaceutical representatives from over 20 countries to New York for the 17th annual mifepristone medical abortion meeting, with the theme “Mifepristone in the Real World: Obstacles and Opportunities. Domestic and global updates were provided by participants as well as information about new science and practice in the field. Among the topics discussed during small group breakout sessions were models of medical abortion service provision including OTC models, same-day services for second trimester inductions, as well as counseling and information needs for women with limited clinical supervision. The second day of the meeting focused on moving mifepristone out of the clinic and into women’s hands, with a range of dynamic speakers sharing perspectives and experiences around harm reduction and self-induction, service delivery strategies and balancing women’s needs with provider’s concerns. We thank our friends and colleagues for another successful meeting!